What we do Prism Medico & Pharmacy Ltd specializes in manufacturing, formulating, and trading pharmaceuticals, drugs, healthcare, and nutraceutical products in India. |
Founded in 1,985 |
Market share A small player in pharmaceuticals with limited operations and ongoing efforts to optimize performance. |
Problem solved Provides quality pharmaceutical and healthcare products addressing medical and wellness needs. |
Top clients or who we serve Healthcare providers, pharmacies, and consumers in pharmaceutical and nutraceutical sectors (B2B and B2C). |
Key management - |
Our journey and innovations Started in 1985 as a trading entity; pivoted to pharmaceuticals in 2012 aligning with industry growth. |
Where we operate India primarily, with import-export of pharmaceutical goods. |
Top products or what we offer Pharmaceuticals, antibiotics, drugs, biologicals, nutraceuticals, ayurvedic and dietary supplements. |
Top brands - |
Raw materials needed Pharmaceutical chemicals, biological materials, and additives for medicine formulation. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue mainly from trading and manufacturing, with fluctuations reflecting operational scale. |
Our industry position Emerging pharmaceutical company focusing on expanding its footprint and product portfolio. |
Financial highlights FY 2024-25 Revenue approx Rs. 63.19 lakh; loss of Rs. 4.87 lakh reported; working to improve cost controls. |
Geographical revenue split Revenue largely from Indian markets, no detailed international split available. |
Order book - |
Whats driving growth Shift towards pharmaceuticals, optimizing costs and product development drive future growth. |
Our future plans Focus on cost control and operational optimization to achieve profitability. |
Our green promise - |
Our people and values - |
Key challenges ahead Scaling operations profitably amidst competition and regulatory compliance. |
Interesting facts Company rebranded in 2012 shifting from animal feed to pharmaceutical products. |
Risks and strategy Operational losses addressed through tighter cost controls and strategic focus on pharmaceuticals. |
